Introduction/objectives: Galectin-3 (Gal-3) is a circulating biomarker of fibrosis. In humans, increased Gal-3 is predictive of myocardial fibrosis and adverse cardiac events. The aim of this study was to evaluate the potential for Gal-3 as a cardiac biomarker in cats with hypertrophic cardiomyopathy (HCM).
Materials And Methods: Eighty cats were enrolled (25 healthy cats with normal hearts, 35 with HCM American College of Veterinary Internal Medicine (ACVIM) stage B, and 21 with HCM ACVIM stage C). Each cat received a full echocardiogram, health panel, and total thyroxin level. Galectin-3 levels were measured for each enrolled patient. Troponin I and N-terminal pro-brain natriuretic peptide (NT-proBNP) were obtained for the majority of cats. Additionally, 17 ACVIM stage B cats underwent cardiac-gated magnetic resonance (CMR) imaging to assess myocardial extracellular volume (ECV), a noninvasive measure of myocardial fibrosis.
Results: Galectin-3 levels are increased in cats with HCM ACVIM stage B and C compared to healthy cats; however, no significant differences were detected between ACVIM stage B and ACVIM stage C cats. In HCM-affected cats, Galectin-3 showed statistically significant correlations with left atrial dimensions, left atrial:aorta ratio, and CMR-derived ECV. Quantitative NT-proBNP showed excellent discrimination between all groups and troponin I was able to discriminate between ACVIM stage C and normal cats, but not between other groups.
Conclusions: Circulating Gal-3 levels are increased in cats with HCM and is positively correlated with left atrial dimensions and ECV in affected cats. Further studies evaluating the relationship between Gal-3, myocardial fibrosis, and clinical outcomes are warranted.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.jvc.2023.06.003 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Metabolic abnormalities and reprogramming in cats with naturally occurring hypertrophic cardiomyopathy.
ESC Heart Fail
November 2024
Department of Clinical Sciences and Advanced Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Background And Aims: The heart is a metabolic organ rich in mitochondria. The failing heart reprograms to utilize different energy substrates, which increase its oxygen consumption. These adaptive changes contribute to increased oxidative stress.
View Article and Find Full Text PDFSafety and efficacy of canine gonadal tissue-derived mesenchymal stem cells for early myxomatous mitral valve disease.
Front Vet Sci
October 2024
Laboratory of Veterinary Internal Medicine, Research Institute for Veterinary Science and College of Veterinary Medicine, Seoul National University, Seoul, Republic of Korea.
Article Synopsis
- This study investigated the use of mesenchymal stem cells (MSC) from gonadal tissue as a potential therapy for dogs with early-stage myxomatous mitral valve disease (MMVD).
- Sixteen dogs were divided into a control group and a treatment group, with the treatment group receiving monthly MSC infusions for one year.
- Results showed that the treatment group maintained stable heart function and delayed progression of MMVD compared to the control group, along with improvements in quality of life, particularly in appetite.
Left atrial volume and function in Cavalier King Charles spaniels at different ACVIM stages.
Res Vet Sci
November 2024
Department of Veterinary Sciences, University of Torino, Largo Braccini 2, Grugliasco, TO, Italy.
Article Synopsis
- The study investigates the size and function of the left atrium in Cavalier King Charles Spaniels (CKCS) with mitral valve disease across different ACVIM stages.
- It finds that certain echocardiographic measures, like left atrial diameter normalized by body weight and various volume measurements, show significant differences between the classes of the disease's progression.
- Results indicate that active left atrial emptying is enhanced in early-stage dogs (ACVIM B1) but decreases in symptomatic cases (C/D), highlighting the presence of atrial remodeling and dysfunction as the disease advances.
Systemic reactive angioendotheliomatosis mimicking hypertrophic cardiomyopathy in a domestic shorthair cat.
J Vet Cardiol
December 2024
Department of Veterinary Biosciences, The Ohio State University, College of Veterinary Medicine, Columbus, OH, USA.
Article Synopsis
- A two-year-old male cat was brought to a veterinary center after showing sudden neurological symptoms and was diagnosed with stage B1 hypertrophic cardiomyopathy via echocardiogram.
- His condition worsened, leading to seizures and panting, ultimately resulting in euthanasia.
- A necropsy revealed a rare condition called systemic reactive angioendotheliomatosis, highlighting the risk of misdiagnosing heart issues in cats based solely on echocardiographic findings.
Evaluation of right ventricular function using conventional and real-time three-dimensional echocardiography in healthy dogs and dogs with myxomatous mitral valve disease.
J Vet Cardiol
December 2024
Department of Small Animal Clinical Sciences, Virginia-Maryland College of Veterinary Medicine, Blacksburg, VA 24061, USA.
Introduction/objectives: To compare conventional and three-dimensional (3D) echocardiographic indices of right ventricular (RV) systolic function in dogs with various stages of myxomatous mitral valve disease (MMVD), classified according to the 2009 guidelines of the American College of Veterinary Internal Medicine (ACVIM), with those from normal dogs.
Animals: Seventy-eight unsedated dogs (22 healthy controls, 23 ACVIM stage B1 MMVD, 20 ACVIM stage B2 MMVD, and 13 ACVIM stage C MMVD) were included in the study.
Materials And Methods: All dogs underwent conventional and 3D echocardiography.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!